Chromosomal 11 alterations in non-small-cell lung carcinomas in Hong Kong

Lung Cancer

Volumn 15, Issue 1, 1996, Pages 51-65

  Chan, Andrew S K ^a   Lam, Wah Kit ^b   Wong, Maria P ^b   Fu, Kin Hang ^c   Lee, Joseph ^c   Yew, Wing Wei ^c   Chiu, S W ^c   Lung, Maria L ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

Chromosome; Genetic alterations; NSCLC

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 11; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; FEMALE; GENE LOCUS; HETEROZYGOSITY; HONG KONG; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE H RAS; PRIORITY JOURNAL;

EID: 0030220849     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(96)00570-3     Document Type: Article

References (25)

1. [1] Bepler G, Garcia-Blanco MA. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA 1994; 91: 5513-5517.
2. [2] Cho KR. Vogelstein B. Genetic alterations in the adenoma carcinoma sequence. Cancer 1992; 70 (Suppl): 1727s-1731s.
3. [3] Feinberg AP. Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
4. [4] Fong KM, Zimmerman PV, Smith PJ. Correlation of loss of heterozygosity at 11p with tumor progression and survival in non-small-cell lung cancer. Genes Chromosomes Cancer 1994; 10: 183-189.
5. [5] Friedman E, Marco LD, Gejman PV, Norton JA, Bale AE, Aurbach GD, Spiegel AM, Marx SJ. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 1992; 52: 6804-6809.
6. [6] Hampton GM, Mannermaa A, Winquist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 1994; 54: 4586-4589.
7. n microsatellite repeats and 13 Alu markers on human chromosome 11 using a panel of somatic cell hybrids. Genomics 1994; 19: 581-584.
8. [8] Iman DS, Harris CC. Oncogenes and tumor suppressor genes in human lung carcinogenesis. Crit Rev Oncol 1991; 2: 161-171.
9. [9] Iwasaki H, Stewart PW, Dilley WG, Holt MS, Steinbrucck TD, Wells SA, Donrs-Keller H. A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95. Genomics 1992; 13: 7-15.
10. [10] Jesudasan RA, Slovak ML, Sen S. Srivatsan ES. Rearrangement of chromosome band 11q13 in HeLa cells. Anticancer Res 1994; 14: 1727-1734.
11. [11] Keldysh PL, Dragani TA, Fleischman EW, Konstantinova LN, Perevoschikov AG, Pierotti MA, Della-Porta G, Kopnin BP. 11q deletion in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer 1993; 6: 45-50.
12. [12] Lam KY, Fu KH, Wong MP, Wang EP. Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology 1993; 25: 103-105.
13. [13] Lung ML, Wong M, Lam WK, Lau KS, Kwan S, Fu KH, Cheung H, Yew WW. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 1992; 70: 760-763.
14. [14] Lung ML, Wong M, Skaanild M, Fok CL, Lam WK, Yew WW. p53 gene mutations in lung carcinomas in Hong Kong. Chest 1996; 109: 718-726.
15. [15] Marshall E. Reports from the front. Science 1995; 267: 1414.
16. [16] Parkin DM, Sankaranarayanan R. Overview on small cell lung cancer in the world: industrialized countries, third world, eastern Europe. Anticancer Res 1994; 14: 277-282.
17. [17] Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). Nucleic Acids Res 1990; 18: 7468.
18. [18] Rasio D, Negrini M, Manenti G, Dragani TA, and Croce CM. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 1995; 55: 3988-3991.
19. [19] Shiraishi M, Morinaga S, Noguchi M, Shimosato Y, Sekiya T. Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn J Cancer Res (Gann) 1987; 78: 1302-1308.
20. [20] Skinner MA, Vollmer R, Huper G, Abbott P, Iglehart JD. Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma. Cancer Res 1990; 50: 2303-2306.
21. [21] Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
22. [22] Speicher MR. Microsatellite instability in human cancer. Oncol Res 1995; 7: 267-275.
23. [23] Strauss WM. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current Protocols in Molecular Biology, Vol. 1. USA: Greene Publishing Associates and Wiley-Interscience, 1989; 2.2.1-2.2.3.
24. [24] Tomlinson GE, Compton DA, Strong LC. PCR detection of a Bgl II RFLP at 11p13. Nucleic Acids Res 1991; 19: 1718.
25. [25] Weston A, Willey JC, Modali R, Sugimurta H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump BF, Harris CC. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 1989; 86: 5099-5103.